Carboprost Tromethamine
Carboprost Tromethamine Injection, USP
Approved
Approval ID
8a1284cf-002f-4887-a3c0-d73d04b2b869
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 1, 2023
Manufacturers
FDA
Xellia Pharmaceuticals USA LLC
DUNS: 116768762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
carboprost tromethamine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70594-112
Application NumberANDA216897
Product Classification
M
Marketing Category
C73584
G
Generic Name
carboprost tromethamine
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateNovember 1, 2023
FDA Product Classification
INGREDIENTS (1)
CARBOPROST TROMETHAMINEActive
Quantity: 250 ug in 1 mL
Code: U4526F86FJ
Classification: ACTIM